Study of the Safety and Activity of Lenvatinib (E7080) in Subjects With KIF5B-RET-Positive Adenocarcinoma of the Lung
Clinical trial NCT01877083 · COMPLETED
Trial details
- NCT number
- NCT01877083
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-05
- Primary completion
- 2016-02-03
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.